More
LONDON -- GlaxoSmithKline is eyeing acquisitions worth $2 billion in India, the world''s fastest-growing drug market, The Economic Times reported.
“India is clearly on the radar. We plan to spend between $500 million and $2 billion. I would love to buy something in India,” GSK Chief Executive Andrew Witty said.
